OR-2805

N/A

Report date: 2022/11/20 14:56:58

Base Information

Drug NameOR-2805
Drug Alias NameOR-2805
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-Scavenger receptor cysteine-rich type 1 protein M130
TargetsScavenger receptor cysteine-rich type 1 protein M130
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOncoResponse Inc
China Registration ClassN/A

Develop Information

Active CompaniesOncoResponse Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A